Skip to content

Public FDA record

Z-1126-2022: (1) Gibeck Humid-Vent 2S Flex DC, Product #17731, sterile; (2) Gibeck Humid-Vent 2S Flex DC, Product #177

Recall record Z-1126-2022 for TELEFLEX MEDICAL INC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1126-2022
Company in FDA record
TELEFLEX MEDICAL INC
FDA record creation date
May 24, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Reports received of torn corrugated breathing tubes.

Source facts

Action
The recalling firm issued letters dated April 2022 on 4/11/2022 via FedEx 2-day mail. The letter described the issue, the immediate actions required including the hazards involved, and provided specific actions to be taken and instructions to be followed by the medical facilities or the distributors. For the medical facilities, they are to cease use and distribution of the impacted product and immediately quarantine it. If the product is in inventory, indicate the information on the Acknowledgment Form and FAX it to Customer Service or email it to the firm. A customer service representative will contact the medical facility with a Return Goods Authorization number and provide instructions for return of the product to Teleflex. The Acknowledgment Form should also be returned if no product is in inventory. For distributors, they are to provide the recall letter to all customers who have received the product. Each customer is required to complete and return the Acknowledgement Form. The distributor is also supposed to check their inventory, cease distribution and quarantine the affected product. The Acknowledgment Form is to be completed and returned for product in their inventory as well as if they have no inventory. If the distributor has distributed product outside of the country, they are to notify Teleflex Customer Service. Additionally, the recall letter says that this notice should be passed onto all persons who need to be aware within their organization or to any organizations where the potentially affected devices have been transferred. This would include users, clinicians, risk managers, supply chain/distribution centers, etc. in the circulation of the notice.
Initiated
2022-04-11
Root cause
Device Design
Distribution
Worldwide distribution - US Nationwide distribution in the states of AL, AR, AZ, CA, CO, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NJ, NV, NY, OH, PA, SC, TN, TX, UT, VA, WA, WI, and WV. The countries of Austria, Australia, Belgium, Canada, Chile, Czech Republic, Finland, France, Germany, Greece, Hong Kong, Hungary, Korea, Malaysia, Netherlands, Panama, Poland, Slovakia, Spain, and Switzerland.
Recall number
Z-1126-2022
Recall status
Open, Classified
CDRH record ID
193159
FDA record created
2022-05-24
Recall event number
90014

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗